Mechanism through Which Retrocyclin Targets Flavivirus Multiplication

Currently, there are no approved drugs for the treatment of flavivirus infection. Accordingly, we tested the inhibitory effects of the novel θ-defensin retrocyclin-101 (RC-101) against flavivirus infection and investigated the mechanism underlying the potential inhibitory effects. First, RC-101 robu...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Xiaoying, Guo, Jiao, Yuan, Weirong, Sun, Lingling, Liu, Yang, Zhou, Minmin, Xiao, Gengfu, Lu, Wuyuan, Garzino-Demo, Alfredo, Wang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Vaccines and Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274595/
https://www.ncbi.nlm.nih.gov/pubmed/33980602
http://dx.doi.org/10.1128/JVI.00560-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274595/
https://www.ncbi.nlm.nih.gov/pubmed/33980602
http://dx.doi.org/10.1128/JVI.00560-21

Ejemplares similares